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a b s t r a c t
Signaling and insulin secretion in b cells have been reported to demonstrate oscillatory modes, with
abnormal oscillations associated with type 2 diabetes. We investigated cellular glucose influx in b cells
with a self-referencing (SR) microbiosensor based on nanomaterials with enhanced performance.
Dose–response analyses with glucose and metabolic inhibition studies were used to study oscillatory pat-
terns and transporter kinetics. For the first time, we report a stable and regular oscillatory uptake of glu-
cose (averaged period 2.9 ± 0.6 min), which corresponds well with an oscillator model. This oscillatory
behavior is part of the feedback control pathway involving oxygen, cytosolic Ca2+/ATP, and insulin secre-
tion (periodicity approximately 3 min). Glucose stimulation experiments show that the net Michaelis–
Menten constant (6.1 ± 1.5 mM) is in between GLUT2 and GLUT9. Phloretin inhibition experiments show
an EC50 value of 28 ± 1.6 lM phloretin for class I GLUT proteins and a concentration of 40 ± 0.6 lM
phloretin caused maximum inhibition with residual nonoscillating flux, suggesting that the transporters
not inhibited by phloretin are likely responsible for the remaining nonoscillatory uptake, and that
impaired uptake via GLUT2 may be the cause of the oscillation loss in type 2 diabetes. Transporter studies
using the SR microbiosensor will contribute to diabetes research and therapy development by exploring
the nature of oscillatory transport mechanisms.
 2010 Elsevier Inc. All rights reserved.
Glucose plays a central role in metabolism, and glucose trans-
port is commonly studied in cancer research (e.g., Wharburg ef-
fect), diabetes, and other cell/tissue culture applications. Changes
in glucose transport are particularly critical in diabetes research.
b cells in the mammalian pancreas secrete insulin [1,2], and
according to the consensus model (triggering pathway) [3,4], glu-
cose enters b cells via glucose transporters (GLUT),1 and is catabo-
lized (glycolysis, TCA, mitochondrial respiration) to produce ATP.
Increased intracellular ATP closes plasmalemma KATP channels,
which depolarizes the membrane and opens voltage-dependent
Ca2+ channels. This influx of Ca2+ triggers the docking of insulin ves-
icles and exocytosis. Subsequent studies have shown that when
cytosolic Ca2+ increases through the triggering pathway, an amplify-
ing pathway is initiated, increasing the efficacy of Ca2+ on exocytosis
of insulin granules [5].
Ca2+/ATP signaling and insulin secretion in b cells exhibit an
oscillatory mode [3,4]. The link among insulin secretion, glucose,
oxygen, calcium, and ATP in pancreatic b cells has led to the devel-
opment of numerous feedback models, for example, increased
intracellular Ca2+ stimulates ATP consumption, reducing the ATP/
ADP ratio, and inducing the reopening of the KATP channels and
the decrease of Ca2+ influx [6]. Other explanations of the oscillatory
mechanisms include oscillatory glycolysis theory [7], multisystem
theory [8], phase control and modulation theory [9], and the dual
oscillator model [10]. Similar periods (around 3 min) have been re-
ported for oxygen influx, cytosolic Ca2+, the ATP/ADP ratio, and
insulin secretion [3,11–14]. Since oscillations correlate with insulin
secretion [7], and the oscillatory secretion of insulin is lost in both
individuals with type 2 diabetes and their near relatives due to
defective temporal coordination of b cell function [15–17], re-
search on oscillation patterns have garnered significant interest
[1–3,7,11].
0003-2697/$ - see front matter  2010 Elsevier Inc. All rights reserved.
doi:10.1016/j.ab.2010.12.019
⇑ Corresponding author at: Physiological Sensing Facility, 1203 W. State Street,
Purdue University, West Lafayette, IN 47907-2057, USA. Fax: +1 765 496 1115.
E-mail address: porterf@purdue.edu (D.M. Porterfield).
1 Abbreviations used: CNTs, carbon nanotubes; CV, cyclic voltammetry; GLUT,
glucose transporter; GOx, glucose oxidase; MWNTs, multiwalled carbon nanotubes;
PBS, phosphate-buffered saline; PI, propidium iodide; SR, self-referencing.
Analytical Biochemistry 411 (2011) 185–193
Contents lists available at ScienceDirect
Analytical Biochemistry
journal homepage: www.elsevier .com/locate /yabio
GLUT2 is the main glucose transporter documented in mouse
pancreatic b cells [18]. However, some studies on glucose uptake
and the maintenance of second phase insulin secretion in GLUT2-
null islets suggest the existence of an unidentified GLUT trans-
porter other than GLUT1 or GLUT3 [19]. Following studies have
subsequently reported that GLUT9 may be the unidentified trans-
porter that participates in the regulation of glucose homeostasis
in addition to GLUT2 [20]. Since mutations in the IPF1/PDX1 gene
cause the development of type 2 diabetes, impaired expression of
GLUT2, and impaired secretion of insulin [21], abnormalities in
glucose transport may be related to the cause of type 2 diabetes.
Thus, studies on transporter kinetics and the pharmacological
modulation may provide further insight into type 2 diabetes.
A number of techniques have been used for measuring glucose
concentration in cells/tissues to understand these transport phe-
nomena. These include 14CO2 radioactivity from [U-14C]glucose
[22], 3H2O from [5-3H]glucose [19], 13C NMR spectroscopy [23],
and microfluorometry assays of 6-phosphogluconate [24]. All these
techniques are complex and invasive (requiring extraction). Thus,
there is now a need for sensitive tools which can directly quantify
glucose transport in the cell/tissue spatial domain under physio-
logical conditions.
Glucose biosensors are based on enzymatic recognition of glu-
cose by glucose oxidase (GOx), where oxidation to gluconic acid
produces H2O2, which is detected using oxidative amperometry
at a potential of +0.3–0.8 V [25]. Based on the highly specific enzy-
matic recognition scheme, glucose biosensors do not respond to
other sugar moieties such as sucrose or fructose [26]. In addition,
since the RPMI culture media for INS 1 contain no sugar moieties
other than glucose, the output signal is completely due to glucose
oxidation. Thus, the selectivity of glucose biosensors is ensured.
Enzyme-based electrochemical glucose biosensors have demon-
strated important applications in measuring glucose, e.g., in single
islets [27] for research. Many of these studies are aimed at enhanc-
ing understanding of fundamental cell biology, and/or improving
the design of point of care diagnostics. In addition to the develop-
ment of enzyme-based glucose biosensors, many researchers have
focused on enhancement of these tools with various nanomaterials
[25,28].
Conductive carbon nanotubes (CNTs) are nanomaterials which
improve biosensor performance by enhanced electrochemical
transduction and/or increased enzyme loading [29]. The major dif-
ficulty for CNT immobilization is that CNTs are highly insoluble
due to aggregation via van der Waals forces among tubes [29].
CNT immobilization approaches using polymers that can suspend
CNTs are the most commonly used. In particular Nafion has re-
ceived a lot of attention due to its superior conductivity, chemical
and mechanical stabilities, strong adhesion to electrode surfaces,
and a low swelling capability in aqueous media [29,30]. In addition
to CNTs, metal nanomaterials such as Pt black are commonly used
to increase electrochemical transduction and electrode effective
surface area [31]. Combining CNTs and metal nanomaterials has
proved to be a valuable approach for improving biosensor perfor-
mance [25,28,32].
Although a wealth of knowledge has been gained regarding the
use of GOxmicrobiosensors incorporating various CNT/nanomateri-
als, most devices are prone to high drift/noisewhen used for analyz-
ing glucose concentrations near cells/tissues under physiological
conditions [33]. In addition, concentration measurements using
classic microsensor techniques are not capable of quantifying the
direction of transport (i.e., flux) [30]. A microsensor technique
developed to improve the signal-to-noise ratio and provide direct
measurement of transmembrane flux is known as self-referencing
(SR) [30,33,34]. The SR microsensor technique has been used
extensively to study important biological phenomena [35–38]. SR
is based on Fick’s first law of diffusion, and involves measurement
of concentration gradients (DC) during oscillatory movement of a







Here J is the analyte flux, D is the molecular diffusion coefficient for
glucose, DC is the measured concentration differential, DX is the
distance between the two measurement positions (30 lm), k is
the amperometric sensitivity of the biosensor, and DI is the differ-
ential measured current output at 500 mV.
This work presents a novel self-referencing Pt black/MWNT/
Nafion/GOx glucose microbiosensor (bionanocomposite sensor)
fabricated from a Pt/Ir microelectrode for direct measurement of
glucose flux under physiological conditions. The biosensor was
specifically designed to ensure that islet/b cell physiology was
not affected by biosensor operation, and that no physical damage
to the bionanocomposite layer occurred (which may potentially
occur during in vivo experimentation). The technique was used to
measure glucose influx in cultured b cells under a wide range of
physiological and pathophysiological conditions to study transport
patterns, transporter kinetics, and the pharmacological effects of
inhibitors on glucose transport.
Materials and methods
Chemicals and reagents
Deionized water (DI) of resistivity 18.2 MX cm (Milli Q) was
used to prepare solutions. PBS (pH 7.4), glucose oxidase (EC
1.1.3.4, 100,000–250,000 units/g, from Aspergillus niger), potassium
chloride (KCl, 99%), potassium ferricyanide (K3Fe(CN)6), Nafion
(5% wt/wt), chloroplatinic acid solution (8% wt/wt), lead acetate
(reagent grade, 95%), phloretin, b mercaptoethanol, HEPES buffer,
sodium pyruvate, glutamine, penicillin, and streptomycin were
purchased from Sigma Aldrich (St. Louis, MO). D-Glucose and so-
dium chloride (NaCl) were purchased from Mallinckrodt Baker,
Inc. (Phillipsburg, NJ). Sodium phosphate (Na2HPO47H2O), potas-
sium phosphate (KH2PO4, monobasic), and potassium cyanide
(KCN) were purchased from Fisher Chemicals (Pittsburg, PA).
MWNTs (–COOH functionalized MWNTs, 95 wt%, 8–15 nm outside
diameter) were purchased from Cheap Tubes, Inc. (Brattleboro, VT).
RPMI 1640 mediumwas purchased from GIBCO (Carlsbad, CA), and
fetal calf serum was purchased from Invitrogen (Carlsbad, CA).
Construction of bionanocomposite sensor
If not specified, all sensor development experiments were car-
ried out at room temperature. Pt black was electrodeposited on a
Pt/Ir microelectrode (PI20033.0A10 Microprobe. Inc., 1–2 lm tip
diameter) using a potentiostat (Applicable Electronics) against a
bare Pt wire (0.5 mm in diameter; Alfa Aesar, Ward Hill, MA) in a
solution of 0.72% chloroplatinic acid and 0.001% lead acetate
(10 V for 1 min). A MWNT solution containing 2 mg MWNT/ml
Nafion was ultrasonicated for 120 min. Two microliters of MWNT
solution was cast on the tip of the microelectrode using a pipette.
The microelectrode was air-dried for 5 min, and then dipped in
100 ll 50 mg GOx/ml PBS for 30 min at 4 C, and stored in the same
solution at 4 C when not in use.
Sensor calibration
Cyclic voltammetry (CV) (a sweeping potential was applied to
the electrode, and the current was recorded) and DC potential
amperometry (a constant potential was applied to the electrode,
and the current response was recorded) were carried out with a
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three-electrode electrochemical (C-3) cell stand (BASi, West
Lafayette, IN) and sensors calibrated according to published
techniques [32].
Imaging
All field emission scanning electron microscopy (FESEM) graphs
of the biosensor were obtained from a Hitachi S-4800 microscope
with a power setting of 5.0 kV and magnification settings of 3.5
and 25 k.
Cell viability
Cell viability was evaluated using a combination of CellTracker
(CellTracker Green CMFGA; Invitrogen Molecular Probes, Carlsbad,
CA) and propidium iodide (PI) (Invitrogen Molecular Probes) cell
stains. Living cells with active intercellular esterase activity stain
green with CellTracker while cells with damaged membranes stain
red with PI. INS 1 cells were originally isolated from a transplanta-
ble rat insulinoma induced by X-ray [39]. INS 1 cells were cultured
in growth medium with 10 lM CellTracter for 40 min, and for an
additional 30 min after culture media were refreshed. The growth
media were aspirated and PBS containing 0.01 mg/ml PI was intro-
duced. Cells were then imaged within 30 min using an Olympus
IX81 confocal microscope equipped with multiwavelength lasers
(488 and 514 nm) and Fluoview FV100 software for image capture.
Self-referencing
The SR system has been described previously [33]. Automated
Scanning Electrode Technique (ASET) software (Science Wares,
Falmouth, MA) and A/D (analog-to-digital) board with DC coupled
differential amplifier, low/high pass filters, and video/data acquisi-
tion system (Applicable Electronics, Inc., Sandwich, MA) were used.
Preamplifier signals were coupled through offset function to dis-
cretely subtract off baseline signals (DC coupling) to allow the dif-
ferential waveform to be sufficiently amplified for digital analysis
of the differential signals [33].
For abiotic validation of glucose flux measurements at 37 C, a
solution containing 3 mM glucose and 0.5% agar was heated to
gel, mixed, injected into a pulled micropipette (tip diameter
50 lm), and allowed to cool at room temperature. The micropi-
pette was mounted and submersed in PBS at 37 C and 30 min
was allowed to create a stable steady-state abiotic glucose concen-
tration gradient near the pipette tip. The microbiosensor was posi-
tioned at the tip surface, and flux was measured by an oscillating
biosensor at a suggested frequency [40] perpendicular to the tan-
gent of the tip surface to prevent mixing and ensure optimal per-
formance. Following a minimum nine measurements, sensor was
positioned 5 lm from tip surface, and flux again recorded. This
step-back process was repeated until no change (<1%) in glucose
efflux was observed. An empirical model was developed based on
concentration measurements for describing the flux, and the corre-
lation coefficient between the measured and the predicted flux was
calculated to describe the performance of the SR biosensor
[33,34,36].
INS 1 cell culture and in vitro tests
INS 1 cells were cultured on 10 cm BD Falcon polystyrene tissue
culture dishes (VWR, West Chester, PA) in RPMI 1640 medium, 10%
fetal calf serum, 50 lmol/l b mercaptoethanol, 10 mmol/l HEPES,
1 mmol/l sodium pyruvate, 2 mmol/l L-glutamine, 100 U/ml of
penicillin, and 100 lg/ml streptomycin. Cultured cells were de-
tached from culture dishes with 0.05% trypsin EDTA solution when
90% confluency was reached. After centrifugation, the cells were
suspended in 4 ml culture media. Suspended cells were deposited
on a 10-cm tissue culture plate (VWR) using a pipette to form
Fig.1. (a) CV in 4 mM FeðCNÞ36 /1 M KNO3 for a bare microelectrode and a bionanocomposite sensor at a scan rate 20 mV/s. Representative surface morphology determined by
FESEM for the tip of bionanocomposite sensors after sequential electrodeposition of (b) Pt black, and (c) a MWNT/Nafion layer (insets demonstrate typical low magnification
images).
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cell-rich droplets (four droplets per plate at different places, 250 ll
per drop, seeding density 1 million cells/ml), and incubated for 2 h
to allow for cellular attachment. Culture media (10 ml) were added
to each dish and cells were incubated for 12 h before all in vitro
experiments. All in vitro tests were conducted on monolayer cul-
tures of attached INS 1 cells incubated in culture media at 37 C.
For flux measurements, a glucose microbiosensor was positioned
at the surface (distance less than 1 lm) of cell clusters using the vi-
deo zoomscope as previously described [30]. Prior to each experi-
ment a background measurement (reference) was taken 3 mm
from the b cell cluster surface for a minimum of 5 min (null inter-
nal control). For all experiments, glucose flux was continuously
measured at the surface of cells for a minimum of 30 min prior
to stimulation/inhibition. Steady-state flux was defined as either
<3% change in oscillation period, or <3% change in flux. As an exter-
nal control, all experiments were repeated in the absence of cells
(sterile media) using the same protocol at 37 C.
Results and discussion
Self-referencing biosensor characterization
Cyclic voltammetry was carried out for characterization of elec-
trochemical behavior on a bare Pt/Ir microelectrode, and a bio-
nanocomposite microbiosensor in FeðCNÞ36 from 0 to +650 mV at
a scan rate 20 mV/s (Fig. 1a). The CV for the bare electrode exhib-
ited a sigmoid curve and steady-state diffusion-limited current,
which is characteristic of microelectrodes [41]. In addition to en-
hanced current, the bionanocomposite sensor also exhibited non-
steady-state diffusion-limited characteristics, likely due to the high
film resistance of the MWNT/Nafion layer [28]. Diffusion-limited
current is defined as ilim = KnFDCr [41], where ilim is the
diffusion-limited current,K is a geometric constant (K = 2p for hemi-
spherical diffusion model), n is the number of electrons transferred
during the redox of FeðCNÞ36 , F is the faradic constant,D is the diffu-
sion coefficient for potassium ferricyanide (6.70 ± 0.02  106 cm2/
s), C is the concentration of potassium ferricyanide (4 mM), and r is
the microelectrode tip radius.
Based on this equation, the ratio of electrode tip radius between
the nanomaterial-modified biosensor and the bare electrode was
estimated to be 11.5. This increase in effective surface area (i.e.,
tip radius measured via CV) is attributed to the deposition of
catalytic nanomaterials [28]. Based on FESEM, low (inset approxi-
mately 60  40 lm) and high magnification images demonstrated
the deposition of homogeneous Pt black and MWNT layers (Fig. 1b
and c). Pt black nanostructures were composed of a continuous
film of amorphous Pt nanoclusters, and the MWNT matrix pro-
vided a highly porous matrix for immobilization of glucose oxidase
via both covalent bonding (bovine serum albumin–glutaraldehyde
linkages) and absorption, which was validated in previous studies
[42,43].
As expected, calibration at 37 C via DC potential amperometry
(+500 mV) indicated significantly higher H2O2 sensitivity for the
bionanocomposite sensor compared with bare Pt electrode
(Figs. 2a and b). Since enzymes were immobilized on the biosensor
via dip coating and there was not an established method to deter-
mine the amount of enzymes immobilized on biosensors, it was
difficult to specify the yield of glucose oxidase immobilization in
terms of enzyme loading. Instead, the accepted convention was
to characterize the amperometric sensitivity to glucose [32,44].
Bionanocomposite sensors exhibited a well-defined linear re-
sponse towards glucose with a sensitivity of 531 ± 149 pA/mM
(n = 3 replicate sensors) and an average response time (t95) of
0.88 s (Fig. 3a and b). Average sensitivity per exposed geometric
tip area was 15.0 ± 2.4 mAmM1 cm2, which is 11–2000 times
higher than previously reported glucose microsensors [27,45,46].
The lower limit of detection was 10 lM, and the linear range was
0.01–17.5 mM glucose with an R2 value of 0.99. This linear range
spans the expected glucose concentration in tissue culture media
(typically 0.5–11.1 mM). Bionanocomposite sensors were stable
for up to 7 days when stored in 50 mg GOx/ml PBS at 4 C (less
than 1% reduction in sensitivity up to Day 2; 11% reduction in sen-
sitivity after Day 7 mainly due to GOx degradation caused by the
H2O2 produced from glucose oxidation [47]). Although design
schemes for glucose biosensors vary depending on application
[25,45], the design used here is simple, robust, and can be used un-
der physiological conditions.
To validate the use of the bionanocomposite sensor in the SR
modality, glucose flux was measured in a known glucose concen-
tration gradient within sterile RPMI media (Fig. 3c). The sensor
was oscillated at a frequency of 0.3 Hz with an excursion distance
of 30 lm (approximately 1.3 s acquisition time at each position).
Based on the measured concentration values near the pipette tip
filled with 3 mM glucose, an empirical Fickian diffusion model
was developed [34] and the correlation between predicted and
measured flux was 0.99; the value of the molecular diffusion coef-
ficient for glucose used was 1.5  106 cm2 s1 [48]. The Fickian
transport model did not include convection terms; thus the corre-
lation between predicted and measured values ensured that the
solution was not stirred by oscillating the sensor (oscillation of
SR microsensors in the 0.2–0.4 Hz range was also verified by
[40]). This abiotic experiment validated the use of the SR bionano-
composite sensor for measuring glucose flux under physiological
conditions (37 C in RPMI culture media).
Fig.2. (a) Representative current response to H2O2 for a bionanocomposite sensor
and a bare electrode. (b) Average linear regression result for averaged current
versus molar concentration of H2O2.
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Glucose uptake in pancreatic b cells
Calibratedbionanocomposite sensorswere positioned at the sur-
face of INS 1 cell clusters and glucose fluxwasmeasured for 60 min.
Themean influxat the cell surface (5.9 ± 1.4 lmol cm2 s1)was sig-
nificantly larger than a background measurement (0.28 ± 0.1
pmol cm2 s1) (P < 0.01, a = 0.05). Regular oscillatory glucose
transport with an average oscillation period of 2.9 ± 0.6 min was
measured (n = 12 replicate confluent cultures) (Fig. 4a).
A simple harmonic oscillator model was developed for describ-
ing the average transport in 12 replicate confluent cell clusters:
J = J0 + a ⁄ sin(2p/T) ⁄ t, where J = glucose influx, J0 = mean glucose
influx (6.41 lmol cm2 s1), a = average amplitude of glucose
oscillations (1.75 lmol cm2 s1), T = average period of oscillation
(2.9 min), and t = time. To quantify the regularity of glucose oscil-
lation, the correlation coefficient between average oscillatory glu-
cose flux and the simple harmonic transport model was
determined to be 0.78 based on a standard statistical approach
(Fig. 4b). For the first time, we report a consistent oscillation pat-
tern in glucose uptake (influx) in b cells which is consistent with
previous measurements of oscillatory O2 uptake in HIT b cells
(average period 3.1 ± 0.1 min) [11], cytosolic Ca2+ concentration
(average period 4.6 ± 0.2 min) [3], ATP/ADP ratio (average period
around 3 min) [14], and 5-HT/insulin secretion from single islets
(average period 3.2 ± 1.2 min) [13]. Comparison studies on oscilla-
tory glucose transport for various b cell lines/islets are underway.
Preliminary results showed regular oscillatory patterns for primary
islets (Supplementary Fig. S1). The oscillation patterns for various
cell lines/islets will be investigated in follow-up studies.
Glucose uptake initiates the insulin secretion pathway [3], and
is correlated to metabolism via the electron transport chain [49].
Oxygen uptake and insulin secretion are regulated via a trans-
membrane feedback control system involving cytosolic ATP/ADP
ratio and Ca2+ concentrations, and membrane bound pumps and
channels [3,12,49]. Thus, one would expect glucose influx to fol-
low a regular oscillatory pattern similar to other oscillations.
Although previous measurements reported oscillations in glucose
concentration in single islets [27], these sensors were used inva-
sively, which potentially damaged the cells. In contrast, the
in vitro technique used in this study was noninvasive at the cell
membrane level. To prove this, we performed confocal imaging
to evaluate cellular status after SR measurements to show active
intracellular esterase activity (stained green) (Fig. 4c) and ob-
served no signs of damaged membranes (otherwise stained red),
confirming the noninvasive nature of the SR technique. Since
the biosensors did not damage cell membranes, the functionality
of the cells was not affected by measurements. In addition, when
the glucose concentration in the perfusion media was changed in
previous studies [27], approximately 7.4 min was required for
steady-state concentration measurements due to glucose diffu-
sion and constant consumption by islets. This represented a sig-
nificant delay for the output signal representing concentration
as reported by [27]. In fact, it is common for living organisms
to create drift in concentration measurements because of the con-
stant biological consumption of glucose, as in [27], resulting in
temporal inaccuracy of the reported measurements. Sometimes
the drift was so significant that the signal reflecting physiological
change was submerged. Such drift was eliminated by self-
referencing biosensors due to the differential concentration mea-
surements and DC coupling [33]. As a result, the output signal of
self-referencing glucose biosensors represents the real-time glu-
cose transport in b cells, islets, and other living organisms [32].
This is a major technological improvement for self-referencing
biosensors over concentration biosensors.
Another key limitation in previous studies is that measure-
ments made using concentration domain microsensors are not
capable of directly quantifying glucose flux due to limitations in
spatiotemporal resolution [30,33,50]. At the extracellular interface,
cell/tissue transport is a function of (i) molecular diffusion (driven
by concentration gradients) and (ii) active transmembrane trans-
port (regulated by metabolism, pumps, and channels); techniques
such as SR are required for discriminating between the two types
of transport [30]. Previous attempts at measuring transmembrane
glucose transport using the SR microsensor technique did not re-
port oscillatory behavior [45], which we attribute to relatively
low temporal resolution, low sensitivity, and use of an AC-coupled
electronic scheme.
Fig.3. (a) Representative current response for a bionanocomposite sensor when
glucose concentration increased from 0.1 to 17.5 mM. (b) Average linear regression
for averaged current versus molar concentration of glucose. (c) Abiotic step-back
experiment from pulled micropipette containing 3 mM glucose and 0.5% agar in PBS
at 37 C. Correlation coefficient (e) between measured (d) and predicted flux (solid
line) was 0.99. All error bars represent the standard error of the arithmetic mean.
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Pharmacology
To test the dependence of oscillatory transport on glucose con-
centration, excess glucose dissolved in growth media was added to
the tissue culture dish after at least three successive oscillations.
We found that adding 0.1 mM glucose did induce a transient met-
abolic response that increased glucose influx by an average of
70 ± 8% (Fig. 5a). However, this was a transient effect and no oscil-
latory influx patterns were measured during the ‘‘peak’’ stimula-
tion, which had an average flux of 20.8 ± 2.2 lmol cm2 s1, and
lasted approximately 9.1 ± 0.8 min. Approximately 6.5 ± 0.4 min
after this peak stimulus, uptake decreased to basal levels, and re-
turned to the nominal baseline oscillating state.
In experiments where we stimulated the cells with 15 mM glu-
cose, peak stimulated glucose uptake was as high as 31.3 ± 4.2
lmol cm2 s1 and lasted for an average of 12.1 ± 0.2 min, during
which time no oscillatory transport was measured (Fig. 5b). The
peak value and duration of flux following addition of 15 mM glu-
cose were significantly higher than those following addition of
0.1 mM glucose (P = 0.013, a = 0.05). This temporal trend in peak
duration was expected, as data suggest saturation of transporters
at glucose concentrations of 15 mM, but not at 0.1 mM [20]. Fol-
lowing this transitory increase, mean glucose flux (18.9 ± 1.8 lmol
cm2 s1) was significantly higher than basal levels (4.6 lmol
cm2 s1) (P < 0.01, a = 0.05, n = 12). The oscillation period before
glucose stimulation (3.1 ± 0.2 min) was not significantly different
than that after stimulation (3.3 ± 0.3 min) (a = 0.05, n = 12). Addi-
tion of excess glucose above 15 mM did not cause a significant dif-
ference in mean uptake (Fig. 5c), which was in accordance with the
maximum stimulus concentration determined by Porterfield et al.
measuring oxygen [11]. The GLUT transport proteins have been
shown to follow Michaelis–Menten-type kinetics. Based on the
average flux after each glucose stimulation, the apparent Km value
for INS 1 cells was calculated to be 6.1 ± 1.5 mM, which was differ-
ent from reported Km for GLUT2 (17 mM) or GLUT9 (1.6 mM) [20].
The results indicated that glucose transport in b cells may be
facilitated by more than one transporter, and the saturation of
transporters with relatively low Km values may biologically affect
transporters with high Km values. Thus, inhibition experiments
targeting specific transporters in knock-out mice are necessary to
determine the types of transporter involved.
To abolish metabolic glucose uptake by b cells after stimulus
(internal negative control), 10 mM KCN was added to each dish
and mixed with a transfer pipette. KCN is a known inhibitor of oxi-
dative phosphorylation and inhibits cytochrome c oxidase via the
heme a3-CuB center [51]. Within 3 min, 10 mM KCN decreased glu-
cose uptake by 99.1 ± 0.4% and no oscillations were observed for
any of the replicates (n = 6) (Fig. 6a and b). To validate that cells
were indeed metabolically inactive, 0.1 mM glucose was again
added to the dish and no significant flux was recorded for any clus-
ter replicates (indicating no active biological uptake of the added
glucose) (Fig. 6a and b). These stimulation–inhibition experiments
clearly indicated that the measured glucose flux at the surface of
INS 1 clusters was due to mitochondrial cell respiration.
Phloretin is a known competitive class I GLUT inhibitor, which
includes GLUT1 [52] and GLUT2 [53] in mammalian cells. In a sep-
arate set of pharmacological experiments, activity of class I GLUT
proteins was inhibited by adding phloretin. A dose–response plot
for phloretin inhibition (using glucose flux as the activity assay)
is presented in Fig. 7a. The calculated EC50 value was 28 ± 1.6 lM
phloretin, and the concentration which caused maximum inhibi-
tion was 40 ± 0.6 lM phloretin. To our knowledge, there have been
no previous studies reporting the EC50 value for phloretin with INS
1 cells.
A representative example of a real-time response experiment
demonstrates the effects of phloretin on glucose flux oscillations.
After addition of 40 lM phloretin, glucose influx was reduced by
64 ± 9% and the oscillatory flux was inhibited (Fig. 7b and c). The
phloretin-mediated cessation of oscillatory glucose transport could
be due to a combination of reduced respiratory ATP production/O2
influx, and disruption of the feedback cascade triggered by glucose
uptake.
Oscillatory metabolism is absent in tissues known to have type
2 diabetes [15] and previous studies showed that impaired glucose
transport due to downregulated GLUT2 in b cells was linked to the
loss of insulin secretion in type 2 diabetes [54]. By inhibiting
GLUT2 via phloretin, we observed the loss of oscillatory transport
at the physiological scale, suggesting that impaired GLUT2 may
Fig.4. (a) Representative oscillatory glucose flux in four replicate confluent INS 1 clusters out of 12 total. Average oscillation period (indicated by a vertical dashed line) was
2.9 ± 0.6 min (n = 12). (b) Average glucose flux (dots, n = 12 replicate confluent INS 1 cells) and harmonic oscillator model (solid line): J = J0 + a  sin(2p/T)  t
(a = 1.75 lmol cm2 s1, T = 2.9 min, J0 = 6.41 lmol cm2 s1). Average basal glucose influx in cultured b cell (INS 1) clusters was 5.9 ± 1.4 lmol cm2 s1 (n = 12). Correlation
coefficient between modeled and measured data was 0.78. (c) Representative confocal microscopy image of INS 1 cells using a viability stain (Cell Tracker); green fluorescence
indicates live cells (esterase activity), and red fluorescence indicates dead cells (propidium iodine).
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be the cause of the absence of oscillations in type 2 diabetes. The
residual nonoscillating flux (ca. 35% of basal average flux) was
likely due to the activity of glucose transport mechanisms which
were not inhibited by phloretin (i.e., those which were not
categorized as class I GLUT proteins). After exposure to 40 lM
phloretin, addition of more of this inhibitor (total concentra-
tion = 80 lM) had no effect on the average glucose flux (Fig. 7b
and c), supporting the hypothesis that transporters not inhibited
by phloretin were responsible for the remaining nonoscillatory
glucose uptake (in addition to passive diffusion). A previous study
reported glucose uptake by GLUT2-null b cells, which was not
attributed to GLUT1 or GLUT3 [19]. Results from this study suggest
that the remaining transport may have been due to non-class I
transporters (e.g., GLUT9 [20,55,56]), although additional detailed
studies are currently underway to investigate this conclusion.
Phloretin concentrations below 1 mM have not been shown to
inhibit glucose transport for class II GLUT proteins or voltage-
dependent transporters such as GLUT9 [55], and results from this
study suggested that these proteins were capable of uptaking glu-
cose, but were unable to maintain oscillatory transport when
GLUT2 was inhibited. Follow-up inhibition studies on GLUT9 with
GLUT2 knock-out mice will provide a more definite answer to this
question.
To abolish electron transport after the phloretin studies, 10 mM
KCN was added to each dish, which completely inhibited glucose
influx (n = 4) (Fig. 7b and c).
Fig.5. (a) Representative glucose flux measured at the surface of cultured INS 1 b
cells during stimulation with 0.1 mM glucose. Three successive oscillations were
measured under basal conditions (average period was 3.1 ± 0.3 min), and cells were
then stimulated by adding cell culture media with excess glucose (total glucose
concentration increased by 0.1 mM). (b) Representative glucose flux during
stimulation with 15 mM glucose. (c) Dose–response analysis of glucose flux in
response to stimulation via excess addition of glucose (error bars represent
standard deviation of the arithmetic mean). The maximum glucose concentration
which caused a stimulatory response (15 mM) is consistent with previous glucose
dose–response analysis of O2 flux into HIT b cells [11].
Fig.6. (a) Following a background measurement (bg), five successive oscillations
were measured (noted as ‘‘at surface’’) prior to stimulation with 0.1 mM glucose.
After stimulation with 0.1 mM glucose (noted as ‘‘stimulation’’), five oscillations
were again measured (noted as ‘‘post-stimulus’’) prior to inhibition of electron
transport by addition of 10 mM KCN (noted as post-KCN). (b) Average data during
stimulation–inhibition experiments in part a (n = 12 replicate confluent clusters).
Oscillation period before glucose stimulation (3.1 ± 0.5 min) was not significantly
different than after stimulation (3.3 ± 0.3 min) (P < 0.01, a = 0.05).
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The combination of high porosity and enhanced catalytic activ-
ity of the bionanocomposite sensor design allowed us to resolve
temporally dynamic oscillations in glucose consumption as theo-
retically predicted [11,12,27]. We attribute the ability to quantify
physiological glucose transport in INS 1 cells to the use of highly
conductive nanomaterials (enhancing amperometric sensitivity,
linear detection range, and effective surface area) and the use of
a DC-coupled electronic scheme (alleviating capacitive signal de-
cay) [33].
The ability to noninvasively quantify transport under physio-
logical and pathophysiological conditions will improve our under-
standing of transport processes associated with type 2 diabetes.
Previous studies have shown that mutations in the IPF1/PDX1 gene
of b cells may lead to the development of type 2 diabetes, causing
impaired expression of GLUT2 and secretion of insulin [21,57]. Our
studies, however, did not use mutated cells. Further studies regard-
ing abnormalities in transport via specific GLUT proteins are
underway in an attempt to link the measurements in the physiome
to abnormalities in the genome. Studies on the glucose transport
activities under various pathophysiological conditions based on
this technique will contribute greatly to the understanding of the
genetic cause(s) of diabetes and the development of potential
therapies.
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